Aleksandra Markovets Selected Research

Paraffin

1/2022

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aleksandra Markovets Research Topics

Disease

13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 06/2015
9	Neoplasms (Cancer) 04/2024 - 06/2015
5	Disease Progression 04/2024 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2020 - 06/2015
1	Adenocarcinoma of Lung 04/2024
1	Kidney Neoplasms (Kidney Cancer) 10/2023
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Epilepsy (Aura) 01/2018

Drug/Important Bio-Agent (IBA)

11	osimertinibIBA 04/2024 - 06/2015
7	ErbB Receptors (EGF Receptor)IBA 04/2024 - 06/2015
6	Tyrosine Kinase InhibitorsIBA 04/2024 - 06/2015
5	Circulating Tumor DNAIBA 11/2023 - 01/2016
3	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 10/2023 - 09/2016
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 06/2015
1	capivasertibIBA 04/2024
1	durvalumabIBA 10/2023
1	thiaclopridIBA 10/2023
1	ParaffinIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Pemetrexed (MTA)FDA Link 01/2020
1	LigandsIBA 01/2020
1	PlatinumIBA 01/2020
1	src-Family KinasesIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2016
1	Cell-Free Nucleic AcidsIBA 06/2015

Therapy/Procedure

2	Therapeutics 12/2022 - 06/2015